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Corticobasal degeneration (CBD) is a progressive neurodegenerative disorder characterized by asymmetric 
parkinsonism associated with apraxia, cortical sensory loss, and alien-limb phenomenon. Neuropsychological testing 
in patients with CBD typically shows deficits in executive functions, praxis, language, and visuospatial functioning, but 
not in memory. We report a CBD patient with severely impaired memory function but relatively mild motor 
symptoms. Detailed neuropsychological assessment showed significant verbal and visual memory deficits accompanied 
by frontal executive dysfunctions. Our observations indicate that CBD can in rare cases present with severe episodic 
memory impairment associated with frontal executive dysfunctions in the early stage of illness.
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Corticobasal degeneration (CBD) is a rare neurode-
generative disorder involving the cortical and subcortical 
structures that causes movement abnormalities with 
several cortical signs including cognitive impairment. 
CBD is clinically characterized by a distinctive levodopa- 
resistant progressive asymmetric dystonic-akinetic-rigid 
syndrome associated with cortical features such as 
apraxia, cortical sensory loss, myoclonus, and alien-limb 
phenomenon.
1,5 However, speech problems and cognitive 
impairment are not frequent in CBD patients. Moreover, 
cognitive functions are usually preserved in the early 
stages of CBD, especially in the memory domain. A 
detailed neuropsychological assessment including epi-
sodic memory tasks has not yet to be reported for 
the typical CBD case. In general, neuropsychological 
assessment in patients with CBD shows deficits in 
executive functions, praxis, language, and visuospatial 
functioning, but not in episodic memory. Here we 
report a CBD patient who had severely impaired 
verbal memory functions with relatively mild motor 
symptoms.
CASE REPORT
A 55-year-old man presented with difficulties in 
hand coordination and dressing himself that had first 
appeared in early 2006. It took him a long time to Kim SK, et al. Severe Episodic Memory Impairment in a Patient With Clinical Features Compatible With Corticobasal Degeneration
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Table.  Detailed neuropsychological assessment results in our patient with corticobasal degeneration (CBD)
Neuropsychological test 　　 　 Raw score Percentile
Attention
　 Digit span (forward) 4 3.29
Digit span (backward) 2 0.01
Language and related function
　 Naming, K-BNT  50 70.54
　 Praxis 0 <16
　 Calculation 7 <16
Visuospatial function
　 Interlocking pentagons 0 <16
　 Rey CFT copying 0 0.01
Memory
　 Three-word registration, recall 0 <16
　 Seoul Verbal Learning Test
　 Free recall (first, second, and third trials) 6 0.05
　 20-minute delayed recall 2 0.03
　 Recognition 15 1.62
　 Rey CFT copying
　 Immediate recall 0 2.39
　 20-minute delayed recall 0 2.68
　 Recognition 15 0.01
Frontal/executive function
　 Controlled Oral Word Association Test
　 Animals and supermarket items 13/9 28.1/5.59
　 Phonemic items (ㄱ,  ㅇ, and ㅅ)2 1 . 3 2
　 Stroop
　 Letter reading/color reading 27/14 <16/<16
K-MMSE 17 0.01
K-BNT; Korean version of the Boston Naming Test, Rey CFT; Rey-Osterrieth Complex Figure Test, K-MMSE; Korean 
version of the Mini-Mental State Examination.
put on his clothes because he had difficulty distin-
guishing between the front and back of clothing, and 
needed assistance with buttoning and zipping up his 
clothing. A severe memory disturbance that had also 
developed was slowly progressing.
A neurological examination showed typical cortical 
signs including severe apraxia, cortical sensory loss, 
myoclonus, and alien-limb phenomenon that predomi-
nantly affected the right arm. There was akinesia and 
rigidityin both extremities, with mild asymmetry. There 
were no prominent visuospatial problems, including 
simultanagnosia, visual inattention, oculomotor apraxia, 
or optic ataxia. A detailed neuropsychological assessment 
revealed prominent verbal and visual memory deficits 
with marked frontal executive dysfunctions (Table). 
The patient scored 17/30 on the Korena version of 
Mini-Mental State Examination, with the subscore 
for time orientation being 3/5 and a delayed three- 
word recall of 0/3. He exhibited an abnormal digit 
span on attention tests and showed severe ideomotor 
and ideational apraxia on several praxis tasks. His 
language functions were relatively preserved. His 
performance on copying in the Rey-Osterrieth Complex 
Figure Test was impaired. On the Seoul Verbal Learning 
Test, he was able to recall two items (＜percentile 1) 
with a 20-minute delayed recall. He also scored poorly 
in delayed recall in the Rey-Osterrieth Complex Figure 
Test (0/36, percentile 2). His performances on the 
tasks of Controlled Oral-Verbal Fluency and Stroop 
Test were also severely impaired.
Brain MRI performed 18 months after the onset of 
the symptoms revealed significant cortical atrophy in Journal of Clinical Neurology: Vol. 4, No. 2, 2008
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Figure 1. Brain MRI showing significant cortical atrophy in both parietal areas, which was more prominent on the left side 
with diffuse cortical atrophic changes in T1-weighted images.
both parietal areas that were more prominent on the 
left side with diffuse cortical atrophic changes in 
T1-weighted images (Fig. 1). Brain PET showed pro-
minent asymmetric (left-dominant) hypometabolism 
in both parietal areas, with significant metabolic deficits 
in the left temporal lobes (Fig. 2). Mildly decreased 
metabolism was also observed in both frontal areas.
DISCUSSION
Cognitive impairments such as severe amnesia and 
visuospatial abnormalities were initially thought to be 
a rare or late presenting trait in CBD, with cognitive 
functions being relatively spared until the late stages 
of CBD and higher mental function being relatively 
preserved in CBD patients.
1,7 Clinical descriptions of 
CBD (mostly from movement disorder clinics) have 
emphasized motor manifestations such as parkin-
sonian features, apraxia, myoclonus, gaze palsies, and 
alien-limb phenomenon. Research focused on the motor 
symptoms may have led to the notion that cognitive 
impairment or dementia occurs only in a few patients 
with CBD.
6,7 Postmortem pathological studies of CBD 
show neuronal loss, swollen achromatic neurons, and 
diffusely stained tau-positive astrocytic plaques. These 
changes typically involve the cortical and subcortical 
areas.
2,3 Asymmetric cortical atrophy involves mainly 
the superior parietal and frontal lobes, with smaller 
effects in the temporal and occipital lobes.
4
Several recent studies have documented that cog-
nitive dysfunctions and language disturbances in the 
early stage of the disease course are not rare manifes-
tations in CBD patients.
8,9 However, the current findings 
related to episodic memory functioning in CBD are 
not described well by comprehensive cognitive assess-
ments. Our patient showed prominent memory impair-
ment in several cognitive domains upon a detailed 
neuropsychological evaluation and history taking by 
his caregiver. The results of the word-list learning 
test as a verbal memory task indicated severe impair-
ment of encoding, resembling the learning process 
frequently seen in patients with Alzheimer’s disease 
(AD). Very few case studies have found abnorma-
lities with respect to episodic memory test using the 
story recall test in patients with CBD.
10-12 In general, 
CBD patients perform better on story recall and word 
list tasks than matched AD patients.
11,13 The impairment 
of episodic memory appears to be less severe in 
CBD patients than in AD patients. In AD, poor strategic 
processes in frontal lobe dysfunctions or disruption 
of frontal-subcortical circuits leads to episodic memory Kim SK, et al. Severe Episodic Memory Impairment in a Patient With Clinical Features Compatible With Corticobasal Degeneration
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Figure 2. Brain FDG-PET imaging with SPM analysis showing prominent asymmetric (left-dominant) hypometabolism on 
both parietal and left temporal areas. Significant hypometabolism was also observed in both frontal lobes.
impairment. However, the pattern of memory deficits 
in our patient differed from that typical of AD.
12  The 
prominent memory deficits in our case can be ex-
plained by additional cortical hypometabolism in the 
left temporal area.
Posterior cortical atrophy
14 can be included in the 
differential diagnosis of CBD. However, there were 
no prominent visual complaints with typical presen-
tations of Balint’s syndrome in our case. Although 
significant visuospatial and constructive dysfunctions 
were observed when our patient was asked to draw 
interlocking pentagons and Rey-Osterrieth figures, 
those deficits were augmented by severe hand apraxia. 
Our patient also showed severe frontal subcortical 
circuit deficits when asked to perform several tasks 
of executive functioning. The frontal lobe dysfunctions 
could be explained by the significant hypometabolism in 
both frontal areas.
In summary, our patient presented with severe 
episodic memory impairment and frontal executive 
dysfunctions at an early stage of CBD. However, 
other neurodegenerative diseases such as AD or other 
focal dementia syndromes associated with parkinso-
nism cannot be completely ruled out without a post-
mortem pathologic diagnosis.
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